- Home
- Johnson & Johnson
Johnson & Johnson
The quest for a global preventive HIV vaccine reaches an exciting milestone with the Mosaico study
Announced ahead of the International AIDS Society Conference on HIV Science in Mexico City, the new study will evaluate an investigational vaccine regimen in eight countries around the world for its ability to protect people from HIV infection.
What it’s like to be the custodian of Johnson & Johnson’s over 135-year history
Not all companies have a Chief Historian. Then again, not all companies have such a long, rich heritage of innovation. Margaret Gurowitz explains the highlights—and delights—of her unique job.
JLABS @ Shanghai: The innovation hub that’s poised to shake up the healthcare start-up scene in Asia
Sharon Chan, head of the first Johnson & Johnson Innovation, JLABS, in Asia, gives us a tour of the exciting new incubator that’s designed to help entrepreneurs turn great ideas into great products.
“Everyone deserves to feel safe": Meet a Johnson & Johnson leader who’s proud to be an ally for the LGBTQIA+ community
For Pride Month, Johnson & Johnson Executive Vice President Ashley McEvoy shares how the company stands behind its LGBTQIA+ employees—and why a strong culture of diversity and inclusion is crucial to successfully finding solutions for the world’s greatest healthcare problems.
Remembering legendary poet Joyce Kilmer—and his surprising link to Johnson & Johnson
As Memorial Day approaches, we’re honoring the life of the famous poet and service member, known for his iconic “Trees” poem, who was the son of the company’s first Scientific Director—and a writer for Johnson & Johnson.
“My life’s mission is finding a way to prevent HIV": Meet the lead scientist on a promising female-focused vaccine trial
A study of women, by women. We’re talking about the Imbokodo trial, which is evaluating an investigational HIV vaccine in sub-Saharan Africa. As the study hits a key milestone, we sat down with South African physician and scientist Glenda Gray, who’s at the helm of the groundbreaking trial.
From the Appalachians to Asia and Africa: Meet a woman who has dedicated her career to improving kids’ futures
A visit back to her Kentucky roots with Save the Children brought Joy Marini full circle—and underscored the importance of the work she does with Johnson & Johnson to help children around the globe.
This researcher made good on his high school promise to improve how we treat depression
As a teenager, Wayne Drevets, M.D., had friends who struggled with depression—and who ultimately inspired him to focus his career on helping people with the debilitating disorder.
New study shows researchers may be one step closer to intercepting lung cancer earlier
A team of scientists, including those from Janssen and the Lung Cancer Initiative at Johnson & Johnson, found that biomarkers related to the immune system may be able to aid doctors in identifying high-risk lung cancer patients—and treating them—at the earliest stage of the disease.
3 innovative ways one company is helping rethink how we treat mental healthcare
From scientists in research labs to CEOs at companies across the country, here’s how one healthcare company is partnering with people from all walks of life to help drive change in how we treat mental disorders—and the stigma often associated with them.